Flow chemistry has become the preferred method for specific synthesis projects, making it essential for drug innovators to understand how to implement the process successfully, from program initiation to scale-up.
In this paper, we look at the factors to consider when evaluating whether to use a batch or flow reaction and discuss a case study that shows the value of integrated capabilities.
